Fabry Disease

Moss-aGal

Start of phase I clinical trial for moss-aGal, the world´s first moss-produced drug candidate ...

Learn more

aHUS disease

Moss-FH

is a recombinant protein in development as a treatment for atypical Haemolytic Uremic Syndrome (aHUS) ...

Learn more

Products & Services

Pipeline

Based on our innovative BryoTechnology platform, we have established a pipeline of proprietary clinical candidates …

Learn more